CLOs on the Move

ITC Nexus Dx

www.itcmed.com

 
ITC is a wholly-owned subsidiary of Thoratec and develops, manufactures and markets medical devices used in three distinct segments of the medical field.
  • Number of Employees: 25-100
  • Annual Revenue: $250-500 Million
  • www.itcmed.com
  • 8 Olsen Ave
    Edison, NJ USA 08820-2419
  • Phone: 732.548.5700

Executives

Name Title Contact Details

Similar Companies

Evermore Cannabis

The Highest Standards For Creating Quality Medical Cannabis Products. Evermore manufactures and processes medical cannabis in the State of Maryland.

National HealthCare Services

National HealthCare Services is a Long Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stockamp and Associates

Stockamp delivers: Stockamp helps high-performing hospitals reach the pinnacle of financial and operational excellence. We invented and perfected the science of revenue cycle management for hospitals and health systems, based on our unmatched

Openfit

Openfit is the place to go to get results and have fun doing it – an all-new digital streaming platform that integrates fitness, nutrition, and wellness together in one place. We offer world-class fitness programs with workouts designed to reach any goal, perfectly paired nutrition plans, safe and effective supplements, and customized wellness advice. In the process, we`ve searched far and wide to bring together the world`s foremost fitness and nutrition experts to make sure you succeed in reaching your goals. Whether you`re training for an extreme event, looking to lose weight, or just wanting to live each day a little healthier than the last – you`ll not only find solutions at Openfit, you`ll find inspiration. The kind that powers you through your workout and leaves you feeling pumped to do it again tomorrow. So you can reach your goals…and want to come back for more. That`s the simplicity of living a healthy, vibrant life – in your own way – every day. We hope you`ll come live yours at Openfit.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.